Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)

Condition:   Infection, Human Immunodeficiency Virus Intervention:   Procedure: Blood sampling Sponsors:   GlaxoSmithKline;   University of Ghent Not yet recruiting

Source: ClinicalTrials.gov - December 11, 2017 Category: Research Source Type: clinical trials